Everolimus-eluting coronary stent

DEVICE2 trials

Sponsors

Dr Peter Barlis, Meril Life Sciences Pvt. Ltd.

Conditions

Coronary Artery DiseaseCoronary Heart Disease

Phase 3

Optical Coherence Tomography Assessment of Intimal Tissue and Malapposition

Dr Peter BarlisCoronary Heart Disease

Start: 2010-10-31End: 2014-12-31Target: 80Updated: 2014-08-05

Unknown Phase

BioMime Vs. Xience Randomised Control Clinical Study

Meril Life Sciences Pvt. Ltd.Coronary Artery Disease

Start: 2014-11-05End: 2019-12-01Updated: 2018-08-17